摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

H-D-Tyr-val-gly-OH

中文名称
——
中文别名
——
英文名称
H-D-Tyr-val-gly-OH
英文别名
2-[[(2S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]acetic acid
H-D-Tyr-val-gly-OH化学式
CAS
——
化学式
C16H23N3O5
mdl
——
分子量
337.37
InChiKey
NWEGIYMHTZXVBP-OCCSQVGLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    146
  • 氢给体数:
    4
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    RAMER, SHAWN E.;CHENG, HENGMIAO;PALCIC, MONICA M.;VEDERAS, JOHN C., J. AMER. CHEM. SOC., 110,(1988) N 25, C. 8526-8532
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Alpha-amidating enzyme compositions and processes for their production and use
    申请人:UNIGENE LABORATORIES INC.
    公开号:EP0308067A2
    公开(公告)日:1989-03-22
    Purified enzymatic compositions are provided having alpha-amidating enzymes capable of catalyzing the conversion of a peptidyl compound having a C-terminal glycine residue to a corresponding peptidyl amide having an amino group in place of the C-terminal glycine. The purified compositions have specific activities above 25mU per mg protein and are sufficiently free of proteases to allow effective catalysis of even peptidyl compounds having L-amino acids. Biologically important alpha-amidated products such as calcitonin and other regulatory hormones are efficiently produced using the alpha-amidation reaction catalyzed by the enzymes. Purification by size exclusion chromatography in combination with strong anion exchange chromatography results in homogeneous enzyme species which are used to prepare antibodies specific for the alpha-amidating enzyme. A gene capable of expressing the alpha-amidating enzyme is ligated into an expression vector and transformed into a host cell capable of expressing the gene.
    所提供的纯化酶组合物具有α-酰胺化酶,能够催化具有 C-末端甘酸残基的肽基化合物转化为相应的肽基酰胺,肽基酰胺具有取代 C-末端甘酸的基。纯化组合物的比活性高于每毫克蛋白质 25mU 的平,并且不含蛋白酶,甚至可以有效催化具有 L-氨基酸的肽化合物。利用该酶催化的α-酰胺化反应,可有效生产出具有重要生物学意义的α-酰胺化产品,如降钙素和其他调节激素。通过尺寸排阻色谱法结合强阴离子交换色谱法进行纯化,可得到均一的酶种类,用于制备针对α-酰胺化酶的特异性抗体。将能够表达α-酰胺化酶的基因连接到表达载体中,并转化到能够表达该基因的宿主细胞中。
  • C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0447547A1
    公开(公告)日:1991-09-25
    A C-terminus amidation enzyme composition of serum or blood plasma origin, which acts on a C-terminus glycine adduct represented by formula (I) (wherein A represents a residue other than α-amino or imino group and α-carboxyl group of a natural α-amino acid origin, and X represents a hydrogen atom or a residue of an amino acid derivative bound to the N atom via a carbonyl group) to produce a C-terminus amidation product represented by formula (II) (wherein A and X are as defined above) and glyoxylic acid, is disclosed. A process for preparing the composition and its use are also disclosed.
    一种来源于血清或血浆的 C-端酰胺化酶组合物,它作用于式(I)代表的 C-端甘酸加合物(其中 A 代表除天然 α-氨基酸来源的 α-基或亚胺基和 α-羧基以外的残基),X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基、和 X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基),以产生由式 (II) 代表的 C 端酰胺化产物(其中 A 和 X 如上定义)和乙醛酸。还公开了制备该组合物的工艺及其用途。
  • Enzyme participating in c-terminal amidation, and method of preparing same and use thereof
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0666318A1
    公开(公告)日:1995-08-09
    An enzyme catalyzing the conversion of a peptide C-terminal glycine adduct represented by the following formula (I): (wherein A represents a residue other than α-amino group or imino group and α-carboxylic group derived from naturally occurring α-amino acid, X represents hydrogen atom or a residue of an amino acid derivative which is bonded to N atom through carbonyl group) to a peptide C-terminal α-hydroxyglycine adduct represented by the following formula (II): (wherein A and X have the same meanings as above), and further catalyzing the conversion of the peptide C-terminal α-hydroxylglycine adduct represented by the above formula (II) to a C-terminal amidated compound represented by the following formula (III): (wherein A and X have the see meanings as defined above), which comprises culturing host cells transformed with an expression plasmid comprising a DNA coding for said enzyme, and recovering both or either of said enzymes from the culture, characterized in that in said DNA a portion corresponding to the membrane spanning region has been excised.
    催化下式(I)所代表的肽 C 端甘酸加合物转化的酶: (其中 A 代表α-基或亚胺基和α-羧基以外的残基,α-基或亚胺基和α-羧基来自天然存在的α-氨基酸,X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基)转化为下式(II)代表的肽 C-末端α-羟基甘酸加合物: (其中A和X的含义同上),并进一步催化由上式(II)代表的肽C-末端α-羟基甘酸加合物转化为由下式(III)代表的C-末端酰胺化化合物: (其中A和X的含义与上式相同),其中包括培养用包含编码上述酶的DNA的表达质粒转化的宿主细胞,并从培养物中回收上述两种或其中一种酶,其特征在于,在上述DNA中,对应于跨膜区的部分已被切除。
  • Enzyme participating in C-terminal amidation, and method of preparing same and use thereof
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0884389A1
    公开(公告)日:1998-12-16
    An enzyme participating in C-terminal amidation which acts on a peptide C-terminal glycine adduct represented by the following formula (I): (wherein A represents a residue other than α-amino group or imino group and α-carboxylic group derived from naturally occurring α-amino acid, X represents hydrogen atom or a residue of an amino acid derivative which is bonded to N atom through carbonyl group) to form a peptide C-terminal α-hydroxylglycine adduct represented by the following formula (II): (wherein A and X have the same meanings as above, and an enzyme participating in peptide C-terminal amidation of a peptide terminal glycine adduct which acts on a peptide C-terminal α-hydroxylglycine adduct represented by the above formula (II) to form a C-terminal amidated compound represented by the following formula (III): (wherein A and X have the same meanings as described above) a method of producing the same, and the use thereof.
    一种参与 C 端酰胺化的酶,它作用于由下式(I)代表的肽 C 端甘酸加合物: (其中 A 代表α-基或亚胺基和α-羧基以外的残基,X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基),以形成下式(II)所代表的肽 C-末端α-羟基甘酸加合物: (其中 A 和 X 的含义同上,以及一种参与肽 C-末端甘酸加合物酰胺化的酶,该酶作用于上式(II)代表的肽 C-末端α-羟基甘酸加合物,形成下式(III)代表的 C-末端酰胺化化合物: (其中A和X的含义与上述相同)的生产方法及其用途。
  • ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0438600B2
    公开(公告)日:2002-10-09
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸